Clinical Trial

Care in Multiple Sclerosis (MS)

Recruiting
View on ClinicalTrials.gov →
Summary
This study is structured around three main aims. In Aim 1, investigators will conduct community-based participatory research (CBPR) to develop culturally tailored methods to assess childhood adversity in multiple sclerosis (MS). Aim 2 will investigate the impact of childhood adversity on MS outcomes among individuals with relapsing-remitting MS (RRMS), among whom 70% belong to a group historically under-represented in MS research: Black, Hispanic, or poverty-impacted. Aim 2 procedures involve two visits that include a research blood draw and an MRI scan. In Aim 3, investigators will conduct interviews and surveys to explore environmental and social factors affecting quality of life for minority MS patients.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-06-02; most recent amendment 2026-04-29.
Status change: Not Yet Recruiting → Recruiting 2025-10-28
Trial Details
NCT Number NCT07011914
Lead Sponsor NYU Langone Health
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Conditions Multiple Sclerosis
Enrollment 300 participants
Start Date 2025-10-23
Primary Completion 2029-06-30 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-05